Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Scott Potenta, MD, PhD
This study will investigate the accuracy of ferumoxytol-enhanced MRI in detecting lymph nodes that have been invaded by tumor cells in patients with colorectal cancer. This study will be performed in addition to any ongoing routine care and will not serve as a substitute for any imaging tests that would be routinely performed prior to surgery.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients 18 years of age or older with histologically confirmed colorectal cancer
Planned for surgical resection of tumor
You may not be if
Contraindications for MRI
Contraindication or known allergy to ferumoxytol or parental iron products (e.g. iron sucrose, iron dextran, etc.)
Planned chemotherapy or radiation treatment prior to surgical resection of primary tumor
Uncontrolled serious medical illness
Unable or unwilling to give informed consent
Pregnancy
Breastfeeding women
Clinically documented or known risk of primary or secondary iron overloading including history of thalassemia, sickle cell anemia, hereditary hemochromatosis or first-degree relative with known hemochromatosis, multiple transfusions for any reason within the past 5 years, or use of over-the-counter ferrous sulfate without the supervision of his/her doctor
